Expanding buprenorphine access in the United States requires evidence-based decision-making that considers both the drug's potential dangers and its potential benefits. Risks associated with buprenorphine misuse and diversion highlight the need for careful, ongoing evaluation during each stage of increased access.
View Article and Find Full Text PDFThis article explores challenges to accessing opioid treatment programs in rural areas, and offers solutions that would ease these problems.
View Article and Find Full Text PDF